NCC Group Valuation
Is NCCl undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
4/6Valuation Score 4/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of NCCl when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: NCCl (£1.56) is trading below our estimate of fair value (£2.51)
Significantly Below Fair Value: NCCl is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NCCl?
Key metric: As NCCl is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
What is NCCl's PS Ratio? | |
---|---|
PS Ratio | 1.5x |
Sales | UK£324.40m |
Market Cap | UK£492.15m |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 1.7x |
Enterprise Value/EBITDA | 14.9x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does NCCl's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.3x | ||
FDM FDM Group (Holdings) | 1.2x | -5.2% | UK£343.7m |
KNOS Kainos Group | 2.8x | 5.7% | UK£1.0b |
KCT Kin and Carta | 1.2x | 9.2% | UK£224.6m |
ECK Eckoh | 4.1x | 7.1% | UK£153.0m |
NCCl NCC Group | 1.5x | 4.5% | UK£492.1m |
Price-To-Sales vs Peers: NCCl is good value based on its Price-To-Sales Ratio (1.5x) compared to the peer average (2.3x).
Price to Sales Ratio vs Industry
How does NCCl's PS Ratio compare vs other companies in the GB IT Industry?
Price-To-Sales vs Industry: NCCl is expensive based on its Price-To-Sales Ratio (1.5x) compared to the European IT industry average (0.9x).
Price to Sales Ratio vs Fair Ratio
What is NCCl's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 1.5x |
Fair PS Ratio | 1.8x |
Price-To-Sales vs Fair Ratio: NCCl is good value based on its Price-To-Sales Ratio (1.5x) compared to the estimated Fair Price-To-Sales Ratio (1.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | UK£1.56 | UK£1.79 +14.8% | 12.3% | UK£2.00 | UK£1.35 | n/a | 6 |
Nov ’25 | UK£1.56 | UK£1.79 +14.8% | 12.3% | UK£2.00 | UK£1.35 | n/a | 6 |
Oct ’25 | UK£1.72 | UK£1.75 +1.6% | 13.0% | UK£2.00 | UK£1.35 | n/a | 7 |
Sep ’25 | UK£1.55 | UK£1.75 +12.5% | 13.0% | UK£2.00 | UK£1.35 | n/a | 7 |
Aug ’25 | UK£1.45 | UK£1.72 +18.1% | 12.7% | UK£2.00 | UK£1.35 | n/a | 7 |
Jul ’25 | UK£1.53 | UK£1.70 +11.1% | 12.1% | UK£2.00 | UK£1.35 | n/a | 7 |
Jun ’25 | UK£1.41 | UK£1.56 +10.6% | 15.5% | UK£2.00 | UK£1.15 | n/a | 8 |
May ’25 | UK£1.33 | UK£1.54 +16.5% | 16.5% | UK£2.00 | UK£1.15 | n/a | 7 |
Apr ’25 | UK£1.25 | UK£1.47 +18.0% | 21.0% | UK£2.00 | UK£0.95 | n/a | 8 |
Mar ’25 | UK£1.25 | UK£1.47 +17.8% | 21.0% | UK£2.00 | UK£0.95 | n/a | 8 |
Feb ’25 | UK£1.21 | UK£1.47 +21.9% | 21.0% | UK£2.00 | UK£0.95 | n/a | 8 |
Jan ’25 | UK£1.29 | UK£1.37 +5.9% | 22.2% | UK£2.00 | UK£0.95 | n/a | 8 |
Dec ’24 | UK£1.22 | UK£1.37 +11.9% | 22.2% | UK£2.00 | UK£0.95 | n/a | 8 |
Nov ’24 | UK£1.10 | UK£1.35 +22.9% | 22.2% | UK£2.00 | UK£0.95 | UK£1.56 | 8 |
Oct ’24 | UK£1.18 | UK£1.38 +16.7% | 22.1% | UK£2.00 | UK£0.95 | UK£1.72 | 7 |
Sep ’24 | UK£1.01 | UK£1.38 +36.9% | 22.3% | UK£2.00 | UK£0.94 | UK£1.55 | 7 |
Aug ’24 | UK£1.00 | UK£1.35 +35.8% | 21.9% | UK£2.00 | UK£0.94 | UK£1.45 | 8 |
Jul ’24 | UK£0.97 | UK£1.35 +39.6% | 21.9% | UK£2.00 | UK£0.94 | UK£1.53 | 8 |
Jun ’24 | UK£0.91 | UK£1.47 +61.5% | 31.2% | UK£2.40 | UK£0.94 | UK£1.41 | 8 |
May ’24 | UK£1.07 | UK£1.74 +63.1% | 26.0% | UK£2.40 | UK£1.17 | UK£1.33 | 8 |
Apr ’24 | UK£1.01 | UK£2.17 +114.3% | 17.1% | UK£2.45 | UK£1.30 | UK£1.25 | 8 |
Mar ’24 | UK£1.71 | UK£2.51 +47.0% | 18.9% | UK£3.63 | UK£2.05 | UK£1.25 | 7 |
Feb ’24 | UK£1.83 | UK£2.68 +46.6% | 14.7% | UK£3.63 | UK£2.40 | UK£1.21 | 7 |
Jan ’24 | UK£1.99 | UK£2.74 +37.5% | 14.7% | UK£3.63 | UK£2.45 | UK£1.29 | 6 |
Dec ’23 | UK£2.15 | UK£2.74 +27.8% | 14.7% | UK£3.63 | UK£2.45 | UK£1.22 | 6 |
Nov ’23 | UK£2.05 | UK£2.72 +32.5% | 15.5% | UK£3.63 | UK£2.35 | UK£1.10 | 6 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Capgemini
€26.2b
Engages in the provision of consulting, digital transformation, technology, and engineering services primarily in North America, France, the United Kingdom, Ireland, the rest of Europe, the Asia-Pacific, and Latin America.
CAPP
€153.25
7D
-4.9%
1Y
-14.3%
Computacenter
UK£2.3b
Provides technology and services to corporate and public sector organizations in the United Kingdom, Germany, France, North America, and internationally.
CCCL
UK£22.26
7D
0.3%
1Y
-18.9%
RingCentral
US$3.2b
Provides cloud communications, video meetings, collaboration, and contact center software-as-a-service solutions worldwide.
0V50
US$34.91
7D
-7.0%
1Y
18.9%